(Q42504757)

1 November 2017

title

Leishmaniasis in Sudan. Post kala-azar dermal leishmaniasis (English)

1 reference

1 November 2017

0 references

visceral leishmaniasis

1 reference

Zijlstra EE

1

1 reference

1 November 2017

el-Hassan AM

series ordinal

2

1 reference

1 November 2017

publication date

1 April 2001

1 reference

Transactions of the Royal Society of Tropical Medicine and Hygiene

1 November 2017

published in

1 reference

1 November 2017

volume

95 Suppl 1

1 reference

1 November 2017

page(s)

S59-76

1 reference

Diffuse cutaneous leishmaniasis in Ethiopia. I. The clinical and histological features of the disease

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990219-6

Post-kala-azar dermal leishmaniasis in the absence of active visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990219-6

Post-kala-azar dermal leishmaniasis in the Sudan: peripheral neural involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990219-6

Post kala-azar dermal leishmaniasis in the Sudan: clinical features, pathology and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990219-6

Sporotrichoid cutaneous leishmaniasis due to Leishmania major of different zymodemes in the Sudan and Saudi Arabia: a comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990219-6

A case of African histoplasmosis from Sudan

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990219-6

Reactivity of various leishmanial antigens in a direct agglutination test and their value in differentiating post-kala azar dermal leishmaniasis from leprosy and other skin conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990219-6

The contrasting roles of CD4+ T cells in intracellular infections in humans: leishmaniasis as an example

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990219-6

Failure of a combination of two antifungal drugs, terbinafine plus itraconazole, in Sudanese post kala-azar dermal leishmaniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990219-6

Leishmania in the Old World: 4. The distribution of L. donovani sensu lato zymodemes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990219-6

Recurrence of kala-azar after PKDL: role of co-factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990219-6

Leishmanin test in post-kala-azar dermal leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990219-6

Biochemical and molecular characterization of Leishmania parasites isolated from an endemic focus in eastern Sudan

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990219-6

Use of the polymerase chain reaction to assess the success of visceral leishmaniasis treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990219-6

Amphotericin B is superior to sodium antimony gluconate in the treatment of Indian post-kala-azar dermal leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990219-6

Kala-azar in displaced people from southern Sudan: epidemiological, clinical and therapeutic findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990219-6

Post-kala-azar dermal leishmaniasis in the Sudan: clinical presentation and differential diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990219-6

High levels of plasma IL-10 and expression of IL-10 by keratinocytes during visceral leishmaniasis predict subsequent development of post-kala-azar dermal leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990219-6

Western blot analysis of humoral immune response to Leishmania donovani antigens in patients with post-kala-azar dermal leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990219-6

A cloned kinetoplast DNA mini-circle fragment from a Leishmania spp. specific for post-kala-azar dermal leishmaniasis strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990219-6

7 January 2021

Distinguishing post-kala-azar dermal leishmaniasis from leprosy: experience in the Sudan

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990219-6

7 January 2021

Tinea versicolor and visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990219-6

7 January 2021

Apparently successful treatment of two cases of post kala-azar dermal leishmaniasis with liposomal amphotericin B

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990219-6

7 January 2021

Detection and characterization of Leishmania in tissues of patients with post kala-azar dermal leishmaniasis using a specific monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990219-6

7 January 2021

An Unusual Case of Leishmaniasis Treated with 4:4′-Diamidino Diphenoxy Pentane

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990219-6

7 January 2021

Successful chemotherapy in experimental leishmaniasis is influenced by the polarity of the T cell response before treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990219-6

7 January 2021

Modulation of the cell-mediated immune response in kala-azar and post-kala-azar dermal leishmaniasis in relation to chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990219-6

7 January 2021

Post-kala-azar dermal Leishmaniasis in an HIV-patient

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990219-6

7 January 2021

Post-kala-azar dermal leishmaniasis with mucosal involvement in a kidney transplant recipient: treatment with liposomal amphotericin B

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990219-6

7 January 2021

The treatment of kala-azar in the Sudan with sodium stibogluconate: a randomized trial of three dosage regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990219-6

7 January 2021

Endemic kala-azar in eastern Sudan: a longitudinal study on the incidence of clinical and subclinical infection and post-kala-azar dermal leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990219-6

7 January 2021

Endemic kala-azar in eastern Sudan: post-kala-azar dermal leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990219-6

7 January 2021

The biochemical and serological taxonomy of Leishmania from the Aethiopian zoogeographical region of Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990219-6

7 January 2021

Use of PCR for diagnosis of post-kala-azar dermal leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990219-6

7 January 2021

Treatment of post-kala-azar dermal leishmaniasis with sodium stibogluconate

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990219-6

7 January 2021

10.1016/S0035-9203(01)90219-6

Identifiers

DOI

1 reference

1 November 2017

1 reference